Insiders Vera Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:09:42 2024-05-13 pm EDT			5-day change	1st Jan Change
40.06 ^USD	-3.06%		-12.30%	+159.69%

May. 10	Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating	MT
May. 09	Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Vera Therapeutics Insider Bought Shares Worth $4,999,990, According to a Recent SEC Filing	Feb. 01	MT
Vera Therapeutics, Inc. Announces Executive Changes	Jan. 08	CI
Vera Therapeutics Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs	23-05-04	CI
Insider Buy: Vera Therapeutics	23-03-30	MT
Insider Buy: Vera Therapeutics	23-03-21	MT
Insider Buy: Vera Therapeutics	23-03-14	MT
Insider Buy: Vera Therapeutics	23-03-03	MT
Insider Buy: Vera Therapeutics	23-02-09	MT
Insider Sell: Vera Therapeutics	22-12-14	MT
Insider Sell: Vera Therapeutics	22-10-20	MT
Insider Sell: Vera Therapeutics	22-10-05	MT
Insider Sell: Vera Therapeutics	22-09-22	MT
Insider Sell: Vera Therapeutics	22-09-14	MT
Insider Sell: Vera Therapeutics	22-09-09	MT
Insider Sell: Vera Therapeutics	22-09-06	MT
Insider Sell: Vera Therapeutics	22-08-23	MT
Insider Sell: Vera Therapeutics	22-08-15	MT
Insider Sell: Vera Therapeutics	22-07-20	MT
Insider Sell: Vera Therapeutics	22-07-15	MT
Vera Therapeutics Appoints Michael Morrissey as Chairman of Board	22-04-12	MT

No results for this search